Sign in

CIK 0001159036 · Large accelerated filer

HALOZYME THERAPEUTICS, INC.

Sign in to watch
Ticker
HALO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
880488686
Phone
(858) 794-8889
Business address
12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
Former names
HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$19,884,955
in 5 filings, $19.9M under 10b5-1 plans

Net −$19,884,955. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-02-09 Torley Helen PRESIDENT AND CEO Grant or award · Performance Stock Units +19,807 51,171
2026-02-09 Torley Helen PRESIDENT AND CEO Grant or award · Performance Stock Units +24,985 144,400
2026-02-09 Torley Helen PRESIDENT AND CEO Grant or award · Performance Stock Units +92,714 92,714
2026-02-05 Torley Helen PRESIDENT AND CEO Option exercise 10b5-1 +10,000 $12.07 $121K 718,719
2026-02-05 Torley Helen PRESIDENT AND CEO Sale 10b5-1 −5,376 $78.38 $421K 713,343
2026-02-05 Torley Helen PRESIDENT AND CEO Sale 10b5-1 −4,624 $78.94 $365K 708,719
2026-02-05 Torley Helen PRESIDENT AND CEO Option exercise · Option to Purchase Common Stock 10b5-1 −10,000 $12.07 $121K 201,923
2026-02-04 Torley Helen PRESIDENT AND CEO Option exercise 10b5-1 +20,000 $12.07 $241K 728,719
2026-02-04 Torley Helen PRESIDENT AND CEO Sale 10b5-1 −9,900 $76.94 $762K 718,819
2026-02-04 Torley Helen PRESIDENT AND CEO Sale 10b5-1 −10,100 $77.54 $783K 708,719
2026-02-04 Torley Helen PRESIDENT AND CEO Option exercise · Option to Purchase Common Stock 10b5-1 −20,000 $12.07 $241K 211,923
2026-02-03 Torley Helen PRESIDENT AND CEO Option exercise 10b5-1 +20,000 $12.07 $241K 728,719
2026-02-03 Torley Helen PRESIDENT AND CEO Sale 10b5-1 −2,551 $74.88 $191K 726,168
2026-02-03 Torley Helen PRESIDENT AND CEO Sale 10b5-1 −9,659 $75.94 $734K 716,509
2026-02-03 Torley Helen PRESIDENT AND CEO Sale 10b5-1 −7,790 $76.73 $598K 708,719
2026-02-03 Torley Helen PRESIDENT AND CEO Option exercise · Option to Purchase Common Stock 10b5-1 −20,000 $12.07 $241K 231,923
2026-01-05 Connaughton Bernadette Director Sale 10b5-1 −2,000 $70.25 $141K 40,123
2026-01-03 Snyder Mark Howard SVP, CHIEF LEGAL OFFICER Option exercise +7,611 38,424
2026-01-03 Snyder Mark Howard SVP, CHIEF LEGAL OFFICER Shares withheld for taxes −4,243 $70.31 $298K 34,181
2026-01-03 Snyder Mark Howard SVP, CHIEF LEGAL OFFICER Option exercise · Restricted Stock Units −7,611 0

Page 12 of 26 · 513 trades